Blog

Categories

Sign Our Petition to Ask High Court End Abortion Loopholes

It is time for the U.S. Supreme Court to end abortion favoritism! Please sign our petition today! In 2014, the Louisiana government passed a law requiring abortion clinics to have admitting privileges to local hospitals, ensuring that abortion businesses abide by the same regulations as other outpatient facilities in Louisiana, thereby consistently protecting the health…

Volunteers Needed for State Fair Outreach

Louisiana Right to Life will share the beauty of life at the State Fair of Louisiana in Shreveport beginning next week! The State Fair begins next Thursday, Oct. 24 and continues through Sunday, Nov. 10. WE NEED YOUR HELP TO SHARE THE PRO-LIFE MESSAGE! We still have a number of open slots for volunteers to…

Supreme Court Will Hear Louisiana’s Admitting Privileges Law Case

PRESS RELEASE OCT. 4, 2019 The U.S. Supreme Court has agreed to hear oral arguments in the case of Louisiana Act 620, the Unsafe Abortion Protection Act, which requires abortion physicians to have admitting privileges at a local hospital. In February the Court granted the Shreveport abortion facility’s emergency stay request after the U.S. Court…

Living Out Pro-Life Values Toward People With Down Syndrome

By Eileen Haupt Reprinted from NRL News Today. Eileen is co-founder, Keep Infants with Down Syndrome (KIDS). The month of October is proclaimed “Down Syndrome Awareness Month,” when we celebrate the lives of individuals with Down syndrome and raise awareness about the genetic condition. It also coincides with the “Respect Life Month,” celebrated in October…

National Right to Life Supports Congressional Call for Continued FDA Restrictions for RU-486 Abortion Method

WASHINGTON–Congressman Jim Banks (R-IN) and Congressman Bob Latta (R-OH) along with many other pro-life members of Congress, submitted a letter to the acting commissioner of the Food and Drug Administration (FDA), Norman Sharpless, M.D., asking that the FDA retain the Risk Evaluation and Mitigation Strategy (REMS) that currently exists in relation to mifepristone (RU-486). RU-486…